Together, these molecular changes alter the phenotype and functionality of mesenchymal stem cells (MSCs), indicating that the IGF2BP2/CSF2/Notch1 pathway plays a role in enhancing tumor-associated traits via epigenetic modulation of the TME (154). The gene discussed is NOTCH1; the disease is neoplasm.